Funding Opportunities

NIH Funding Opportunities

Request for Information: Strategies to Strengthen High-Impact NIAMS Clinical Trials
Notice NOT-AR-15-019 from the NIH Guide for Grants and Contracts
Wed, 02 Sep 2015 09:10:54 EST

Research Centers for Cancer Systems Biology Consortium(U54)
Funding Opportunity RFA-CA-15-014 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) will fund a new Cancer Systems Biology Consortium (CSBC) that includes U54 CSBC Research Centers, a Coordinating Center (to be supported under companion U24 RFA-CA-15-015) and other related research projects supported through the U01 mechanism. The CSBC initiative aims to address challenges of complexity in basic and translational cancer research through the use of experimental biology combined with in silico modeling, multi-dimensional data analysis, and systems engineering.
Wed, 02 Sep 2015 01:22:52 EST

Coordinating Center for Cancer Systems Biology Consortium (U24)
Funding Opportunity RFA-CA-15-015 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) will fund a new Cancer Systems Biology Consortium (CSBC) that includes the U24 Coordinating Center (to be supported under this RFA-CA-15-015), U54 CSBC Research Centers (to be supported under companion RFA-CA-15-014), and other relevant research projects supported through the U01 funding mechanism. The CSBC initiative aims to address challenges of complexity in basic and translational cancer research through the use of experimental biology combined with in silico modeling, multi-dimensional data analysis, and systems engineering.
Wed, 02 Sep 2015 01:22:57 EST

Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (UC4)
Funding Opportunity RFA-DK-16-008 from the NIH Guide for Grants and Contracts. This FOA will support the conduct of advanced clinical trials designed to test the outpatient clinical safety and efficacy of artificial pancreas (AP) device systems in type 1 diabetes with the objective of improving glycemic control, reducing acute complications and improving quality of life. These trials should generate data able to satisfy safety and efficacy requirements by regulatory agencies regarding the clinical testing of AP device systems.
Wed, 02 Sep 2015 01:28:51 EST

Sickle Cell Disease in Sub-Saharan Africa: Collaborative Consortium (U24)
Funding Opportunity RFA-HL-17-006 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications that propose to develop a Sickle Cell Disease (SCD) in Sub-Saharan Africa (SSA) Collaborative Consortium. The Collaborative Consortium will be responsible for developing an infrastructure upon which a future SCD in SSA Research Network can be built. This Collaborative Consortium will be comprised of a Consortium Hub (applicant institution) and at least two Collaborating Sites located in sub-Saharan African countries separate from that of the applicant institution.This program is intended to establish an SCD resource that can be shared across the collaborative consortium to enhance future research endeavors.
Tue, 01 Sep 2015 10:49:28 EST

Sickle Cell Disease in Sub-Saharan Africa: Data Coordinating Center (U24)
Funding Opportunity RFA-HL-17-007 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications that propose to develop a Sickle Cell Disease (SCD) in Sub-Saharan Africa (SSA) Data Coordinating Center (DCC) that will support the activities of the SCD in SSA Collaborative Consortium (RFA-HL-17-006). The Collaborative Consortium comprised of a Consortium Hub and at least two additional Collaborating Sites will be responsible for developing the infrastructure for a future SCD in SSA Research Network.
Tue, 01 Sep 2015 10:49:12 EST

Limited Competition: Multi-scale Molecular Profiling of Brains from Psychiatric Cohorts (Collaborative R01)
Funding Opportunity RFA-MH-16-230 from the NIH Guide for Grants and Contracts. The purpose of this limited competition Funding Opportunity Announcement (FOA) and the companion FOA is to seek applications to explore and establish a comprehensive landscape of multi-modal molecular alterations across brain regions, leveraging an existing human brain collection that includes the brains of patients with psychiatric disorders with the goal of developing molecular models of those disorders.This limited competition is open to the Common Mind Consortium and the PsychENCODE Consortium investigators who have access to existing large, high quality, and phenotypically well-characterized brain collections.
Tue, 01 Sep 2015 11:10:58 EST

Limited Competition: Multi-scale Molecular Profiling of Brains from Psychiatric Cohorts (R01)
Funding Opportunity RFA-MH-16-235 from the NIH Guide for Grants and Contracts. The purpose of this limited competition Funding Opportunity Announcement (FOA) and the companion FOA is to seek applications to explore and establish a comprehensive landscape of multi-modal molecular alterations across brain regions, leveraging existing human brain collections that include the brains of patients with psychiatric disorders, with the goal of developing molecular models of those disorders.This limited competition is open to the Common Mind Consortium and the PsychENCODE Consortium investigators who have access to existing large, high quality, and phenotypically well-characterized brain collections.
Tue, 01 Sep 2015 11:11:07 EST

High Impact Neuroscience Research Resource Grants (R24)
Funding Opportunity RFA-NS-16-005 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) supports high impact efforts to make resources available to neuroscience researchers. Projects should engage in one or more of the following activities: propagation of cutting edge reagents or techniques, dissemination of resources to new user groups, or innovative approaches to increase the scale/efficiency of resource production and delivery. Applications focused on technology or software development are not responsive to this FOA, as the focus is on dissemination or provision of resources. Use of existing technologies to develop new reagents or genetic lines of clear value may be appropriate. Projects should address compelling needs of broad communities of neuroscience researchers or should offer unique services that otherwise would be unavailable. Projects must support the NINDS mission.
Mon, 31 Aug 2015 03:04:53 EST

NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)
Funding Opportunity PAR-15-340 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in all areas of cancer research. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical).
Tue, 01 Sep 2015 09:36:41 EST